首页> 外文期刊>Progress in Neuro-Psychopharmacology & Biological Psychiatry: An International Research, Review and News Journal >Acute and chronic effects of electroconvulsive treatment on oxidative parameters in schizophrenia patients
【24h】

Acute and chronic effects of electroconvulsive treatment on oxidative parameters in schizophrenia patients

机译:电痉挛治疗对精神分裂症患者氧化参数的急性和慢性影响

获取原文
获取原文并翻译 | 示例
       

摘要

Electroconvulsive therapy (ECT) is an effective treatment alternative for schizophrenia. Previous studies have already indicated the possible effects of oxidative stress in this disorder. However, there have been no previous studies evaluating the effects of ECT on the oxidative stress in these patients. We therefore aimed to investigate the acute and chronic effects of ECT on serum levels of oxidant and antioxidant molecules in schizophrenia patients (n = 28). The serum MDA and CAT levels of the patients with schizophrenia were higher than that of the controls before ECT (n = 20) but there was no significant difference in the serum NO and GSH levels of the patient groups compared to the controls. We found that the NO levels of the patients were higher than the controls in the group experiei?cing their first episode but not in the chronic group. There was a significant clinical improvement in the patients in terms of BPRS, SANS and SAPS reduction after the 9th ECT, but not the 1st ECT. Serum MDA levels were significantly reduced compared to the baseline after the 9th ECT session although there was no significant difference after the 1st session. Separate evaluation of the patient groups revealed that the significant MDA decrease following ECT was in the patients experiei?cing their first episode and not in the chronic group. No significant difference was noted in the serum levels of other oxidant and antioxidant molecules after either the 1st or 9th ECT session. These results suggest that ECT does not produce any negative effect on oxidative stress in patients with schizophrenia.
机译:电抽搐疗法(ECT)是精神分裂症的有效替代疗法。先前的研究已经表明氧化应激可能对这种疾病产生影响。但是,以前没有研究评估ECT对这些患者氧化应激的影响。因此,我们旨在研究ECT对精神分裂症患者(n = 28)血清中氧化剂和抗氧化剂分子水平的急性和慢性影响。精神分裂症患者的血清MDA和CAT水平高于ECT之前的对照组(n = 20),但与对照组相比,患者组的血清NO和GSH水平没有显着差异。我们发现在经历首次发作的组中,患者的NO水平高于对照组,而在慢性组中则没有。在第9次ECT后,患者的BPRS,SANS和SAPS减少方面有显着的临床改善,但第一次ECT没有。第九届ECT会议后,血清MDA水平较基线水平明显降低,尽管第一届会议后无明显差异。对患者组的单独评估显示,ECT后MDA的显着降低是在经历首次发作的患者中,而非慢性组。在第1次或第9次ECT疗程后,其他氧化剂和抗氧化剂分子的血清水平无显着差异。这些结果表明,ECT对精神分裂症患者的氧化应激没有任何负面影响。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号